Basics |
Company: |
Edwards Lifesciences Corp |
IPO Date: |
April 3, 2000 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$44.46B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.98 | 1.07%
|
Avg Daily Range (30 D): |
$0.68 | 0.94%
|
Avg Daily Range (90 D): |
$0.75 | 1.08%
|
Institutional Daily Volume |
Avg Daily Volume: |
4.73M |
Avg Daily Volume (30 D): |
3.67M |
Avg Daily Volume (90 D): |
4.43M |
Trade Size |
Avg Trade Size (Sh.): |
336 |
Avg Trade Size (Sh.) (30 D): |
79 |
Avg Trade Size (Sh.) (90 D): |
84 |
Institutional Trades |
Total Inst.Trades: |
25,206 |
Avg Inst. Trade: |
$5.85M |
Avg Inst. Trade (30 D): |
$9.52M |
Avg Inst. Trade (90 D): |
$7.85M |
Avg Inst. Trade Volume: |
.16M |
Avg Inst. Trades (Per Day): |
5 |
Market Closing Trades |
Avg Closing Trade: |
$19.7M |
Avg Closing Trade (30 D): |
$73.25M |
Avg Closing Trade (90 D): |
$62.57M |
Avg Closing Volume: |
384.42K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$6.92
|
$5.14
|
$.61
|
Diluted EPS
|
$6.9
|
$5.13
|
$.61
|
Revenue
|
$ 6.31B
|
$ 1.35B
|
$ 1.39B
|
Gross Profit
|
$ 4.84B
|
$ 1.09B
|
$ 1.1B
|
Net Income / Loss
|
$ 4.16B
|
$ 3.07B
|
$ 365M
|
Operating Income / Loss
|
$ 1.68B
|
$ 350.6M
|
$ 369.1M
|
Cost of Revenue
|
$ 1.48B
|
$ 262.9M
|
$ 285.3M
|
Net Cash Flow
|
$ 2.27B
|
$ 2.03B
|
$ 429.1M
|
PE Ratio
|
10.00
|
|
|
Splits |
Jun 01, 2020:
1:3
|
Dec 14, 2015:
1:2
|
May 28, 2010:
1:2
|
|